Get the Stockscreener App
2.19
0.93%
0.03
Sab Biotherapeutics Inc stock is traded at $2.19, with a volume of 21,992.
It is up +0.93% in the last 24 hours and down -1.58% over the past month.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
See More
Previous Close:
$2.16
Open:
$2.15
24h Volume:
21,992
Relative Volume:
0.02
Market Cap:
$22.70M
Revenue:
-
Net Income/Loss:
$-45.57M
P/E Ratio:
-0.3476
EPS:
-6.3
Net Cash Flow:
$-38.56M
1W Performance:
-21.86%
1M Performance:
-1.58%
6M Performance:
+34.57%
1Y Performance:
-19.56%
1-Day Range:
$2.11
$2.185
1-Week Range:
$2.11
$2.90
52-Week Range:
$1.00
$6.60
Sab Biotherapeutics Inc Stock (SABS) Company Profile
Name
Sab Biotherapeutics Inc
Sector
Industry
Phone
305-845-2813
Address
777 W 41ST ST, MIAMI BEACH
Compare SABS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SABS
Sab Biotherapeutics Inc
|
2.18 | 23.53M | 0 | -45.57M | -38.56M | -6.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
377.44 | 97.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.76 | 59.56B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
555.12 | 60.19B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
705.26 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
326.60 | 36.14B | 3.81B | -644.79M | -669.77M | -6.24 |
Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-17-25 | Initiated | Leerink Partners | Outperform |
| May-14-25 | Resumed | H.C. Wainwright | Buy |
| Oct-09-24 | Initiated | Craig Hallum | Buy |
| Aug-28-24 | Initiated | Oppenheimer | Outperform |
| Nov-05-21 | Initiated | Chardan Capital Markets | Buy |
Sab Biotherapeutics Inc Stock (SABS) Latest News
Using data filters to optimize entry into SAB Biotherapeutics Inc.July 2025 Movers & Daily Stock Trend Reports - newser.com
Using R and stats models for SAB Biotherapeutics Inc. Equity Warrant forecasting2025 Trading Volume Trends & Weekly High Conviction Trade Ideas - newser.com
Visual trend scoring systems applied to SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Review & Daily Chart Pattern Signals - newser.com
Can technical indicators confirm SAB Biotherapeutics Inc.’s reversalPortfolio Gains Summary & Safe Entry Momentum Stock Tips - newser.com
Is SAB Biotherapeutics Inc. stock reversal real or fake2025 Market WrapUp & High Accuracy Swing Entry Alerts - newser.com
Will a bounce in SAB Biotherapeutics Inc. Equity Warrant offer an exitTrade Ideas & Daily Stock Momentum Reports - newser.com
Full technical analysis of SAB Biotherapeutics Inc. stockEarnings Overview Report & Safe Entry Momentum Stock Tips - newser.com
Strategies to average down on SAB Biotherapeutics Inc. Equity Warrant2025 Volume Leaders & Verified Momentum Stock Watchlist - newser.com
Is SAB Biotherapeutics Inc. stock bottoming out2025 Price Momentum & Expert Approved Trade Ideas - newser.com
Will SAB Biotherapeutics Inc. see short term momentumJuly 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com
Identifying reversal signals in SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Institutional & Technical Confirmation Alerts - newser.com
SAB Biotherapeutics stock maintains Buy rating at H.C. Wainwright on positive diabetes treatment data - Investing.com
How to build a dashboard for SAB Biotherapeutics Inc. stock2025 Dividend Review & Community Consensus Trade Alerts - newser.com
Forecasting SAB Biotherapeutics Inc. Equity Warrant price range with options dataCEO Change & Accurate Intraday Trade Tips - newser.com
Institutional scanner results for SAB Biotherapeutics Inc. Equity WarrantJuly 2025 Decliners & Real-Time Market Sentiment Alerts - newser.com
SAB Biotherapeutics Inc. Equity Warrant stock prediction for this weekJuly 2025 Update & Free Long-Term Investment Growth Plans - newser.com
Chardan Capital Reaffirms Buy Rating for SAB Biotherapeutics (NASDAQ:SABS) - Defense World
Is it time to cut losses on SAB Biotherapeutics Inc. Equity Warrant2025 Analyst Calls & Free Community Supported Trade Ideas - newser.com
S P Trends: Will SAB Biotherapeutics Inc outperform during market ralliesRate Cut & Stepwise Trade Signal Implementation - خودرو بانک
SAB Biotherapeutics, Inc. (NASDAQ:SABS) Receives Average Rating of “Buy” from Analysts - Defense World
Will SAB Biotherapeutics Inc. bounce back from current supportBull Run & Free Expert Approved Momentum Trade Ideas - newser.com
SABS News Today | Why did SAB Biotherapeutics stock drop today? - MarketBeat
SAB Biotherapeutics (NASDAQ:SABS) Upgraded at Wall Street Zen - Defense World
Q3 Earnings Estimate for SABS Issued By Leerink Partnrs - Defense World
Will SAB Biotherapeutics Inc. Equity Warrant stock go up soonJuly 2025 Big Picture & Safe Entry Momentum Stock Tips - newser.com
Does SAB Biotherapeutics Inc. qualify in momentum factor screening2025 Support & Resistance & Safe Entry Zone Tips - newser.com
Aug Outlook: Is SAB Biotherapeutics Inc stock a falling knife or bargain buyJuly 2025 Update & Long-Term Safe Investment Ideas - خودرو بانک
Aug Reactions: Is SAB Biotherapeutics Inc. Equity Warrant stock undervalued right nowJuly 2025 Levels & AI Powered Market Trend Analysis - خودرو بانک
what data driven models say about sab biotherapeutics inc.’s futureQuarterly Investment Review & Advanced Technical Signal Analysis - newser.com
Is SAB Biotherapeutics Inc. stock poised for growthQuarterly Market Summary & Daily Price Action Insights - newser.com
Intraday pattern recognizer results for SAB Biotherapeutics Inc.Portfolio Growth Summary & Community Verified Trade Alerts - newser.com
Chart based exit strategy for SAB Biotherapeutics Inc. Equity WarrantMarket Movers & Verified Technical Signals - newser.com
Stock Report: Should you buy the dip on Allakos IncJuly 2025 Momentum & Fast Gain Swing Trade Alerts - khodrobank.com
Signal Recap: What’s next for SAB Biotherapeutics Inc. stock2025 Geopolitical Influence & Weekly High Return Stock Opportunities - خودرو بانک
What institutional flow reveals about SAB Biotherapeutics Inc.July 2025 WrapUp & Verified Chart Pattern Signals - newser.com
Whats the beta of Vision Marine Technologies Inc stock2025 Technical Overview & Precise Swing Trade Alerts - khodrobank.com
SAB BIO Highlights Data in Multiple Presentations at EASD - GlobeNewswire
Breakthrough in Type 1 Diabetes: SAB BIO's SAB-142 Shows Sustained Effects Without Lymphodepletion in Phase 1 - Stock Titan
Published on: 2025-09-19 14:28:48 - خودرو بانک
Risk Off: Can CVRx Inc weather a recessionWeekly Trade Review & Daily Volume Surge Signals - khodrobank.com
Aug Swings: What is SAB Biotherapeutics Inc. Equity Warrant’s TAM (Total Addressable Market)July 2025 Review & Weekly Momentum Picks - خودرو بانک
SAB Biotherapeutics Inc. Equity Warrant stock trendline breakdownPortfolio Growth Summary & High Accuracy Trade Alerts - newser.com
What moving averages say about SAB Biotherapeutics Inc.Quarterly Profit Review & Daily Oversold Bounce Ideas - newser.com
Published on: 2025-09-19 05:54:36 - خودرو بانک
institutional scanner results for sab biotherapeutics inc. equity warrantPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Regression analysis insights on SAB Biotherapeutics Inc. Equity Warrant performanceMarket Performance Report & High Accuracy Investment Signals - newser.com
Top Moving Stock Now – SAB Biotherapeutics Inc (NASDAQ: SABS) - stocksregister.com
Will breakout in SAB Biotherapeutics Inc. Equity Warrant lead to full recoveryOil Prices & Free Technical Pattern Based Buy Signals - newser.com
SAB Biotherapeutics Presents Phase I Data on SAB-142 Showing Transient Lymphocyte Declines in Healthy Volunteers at 2025 EASD Conference - geneonline.com
Sab Biotherapeutics Inc Stock (SABS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):